Melatonin as a potential antihypertensive treatment

Area of Science:

• Cardiovascular Research
• Endocrinology
• Pharmacology

Background:

• Hypertension affects millions globally, with inadequate control rates necessitating novel therapeutic strategies.
• Melatonin, a hormone regulating circadian rhythms, shows potential in blood pressure management.
• Reduced nighttime melatonin production is observed in hypertensive individuals.

Purpose of the Study:

• To review the role of melatonin in blood pressure regulation.
• To explore potential mechanisms by which melatonin influences blood pressure.
• To identify areas for future clinical research in melatonin's use for hypertension.

Main Methods:

• Literature review of studies on melatonin and blood pressure in animal models and humans.
• Analysis of proposed mechanisms including antioxidant effects, autonomic nervous system modulation, and receptor interactions.
• Identification of gaps in current knowledge regarding melatonin's clinical application in hypertension.

Main Results:

• Melatonin administration demonstrated blood pressure reduction in various hypertensive models and human subjects.
• The most significant effects were noted in patients with non-dipping nighttime blood pressure.
• Potential mechanisms involve improved endothelial function, autonomic nervous system balance, and direct receptor effects.

Conclusions:

• Melatonin shows promise as a potential adjunct therapy for hypertension, particularly for non-dipping hypertension.
• Further large-scale clinical trials are essential to establish optimal dosing, patient selection, and interactions with existing antihypertensive medications.
• Investigating melatonin's anti-remodeling effects and its role in conjunction with other drugs warrants further study.